Aída Ortega Candil

Aída Ortega Candil

Auto-generated profile, based on publicly available information

Aída Ortega Candil

Nuclear Medicine Department (A.O.), Hospital Clínico San Carlos, Madrid, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2012 in ISRN Dermatology
Verified
Journal Article
Open access
PDF file
ACAída Ortega Candil
Aída Ortega Candil
CRCristina Rodríguez Rey
Cristina Rodríguez Rey
JDJosé Luis Carreras Delgado
José Luis Carreras Delgado
Nuclear medicine plays an essential role in the correct staging of patients suffering from melanoma. Both sentinel lymph node biopsy (SLNB) and positron emission tomography (PET) represent its main diagnostic tools. SLNB is the choice procedure for lymphatic regional staging of these patients, including the result of this technique in the 2002 American Joint Cancer Committee melanoma staging. SLNB sensitivity is superior than PET/CT for the detection of lymphatic micrometastases in early stages of the disease. PET/CT is mainly used in confirming clinical metastases suspected, detection of recurrences, and recurrence restaging. PET/CT has also shown superiority against conventional diagnostic methods in the detection of distant metastases, being able to detect illness even six months earlier than those methods.

1 April 2021 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
CPCarlos Nicolás Pérez-García
Carlos Nicolás Pérez-García
NLNoemí Ramos López
Noemí Ramos López
MFMarcos Fragiel-Saavedra
Marcos Fragiel-Saavedra
AOAida Ortega
Aida Ortega
ABAna Bustos
Ana Bustos
IVIsidre Vilacosta
Isidre Vilacosta